1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014

Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014" provides data on the Germinomatous (Seminomatous) Germ Cell Tumors clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Germinomatous (Seminomatous) Germ Cell Tumors. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Germinomatous (Seminomatous) Germ Cell Tumors. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Germinomatous (Seminomatous) Germ Cell Tumors 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Germinomatous (Seminomatous) Germ Cell Tumors to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Germinomatous (Seminomatous) Germ Cell Tumors to Oncology Clinical Trials 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Drugs 24
Clinical Trial Overview of Top Institutes / Government 25
National Cancer Institute 25
Clinical Trial Overview of National Cancer Institute 25
European Organization for Research and Treatment of Cancer 26
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 26
Children's Oncology Group 27
Clinical Trial Overview of Children's Oncology Group 27
The Royal Marsden NHS Foundation Trust 28
Clinical Trial Overview of The Royal Marsden NHS Foundation Trust 28
Barts and The London NHS Trust 29
Clinical Trial Overview of Barts and The London NHS Trust 29
Sheffield Teaching Hospitals NHS Foundation Trust 30
Clinical Trial Overview of Sheffield Teaching Hospitals NHS Foundation Trust 30
Indiana University School of Medicine 31
Clinical Trial Overview of Indiana University School of Medicine 31
Abramson Cancer Center 32
Clinical Trial Overview of Abramson Cancer Center 32
Medical Research Council 33
Clinical Trial Overview of Medical Research Council 33
Alberta Health Services 34
Clinical Trial Overview of Alberta Health Services 34
Five Key Clinical Profiles 35
Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 58
Secondary Research 58
About GlobalData 59
Contact Us 59
Disclaimer 59
Source 60

List of Tables
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials by Region, 2014* 6
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Germinomatous (Seminomatous) Germ Cell Tumors to Oncology Clinical Trials, G7 Countries (%), 2014* 14
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Germinomatous (Seminomatous) Germ Cell Tumors to Oncology Clinical Trials, E7 Countries (%), 2014* 17
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 25
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014* 26
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014* 27
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by The Royal Marsden NHS Foundation Trust, 2014* 28
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Barts and The London NHS Trust, 2014* 29
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheffield Teaching Hospitals NHS Foundation Trust, 2014* 30
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2014* 31
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2014* 32
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Council, 2014* 33
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Health Services, 2014* 34

List of Figures
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Germinomatous (Seminomatous) Germ Cell Tumors to Oncology Clinical Trials, G7 Countries (%), 2014* 14
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Germinomatous (Seminomatous) Germ Cell Tumors to Oncology Clinical Trials, E7 Countries (%), 2014* 17
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
GlobalData Methodology 58

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.